Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Update

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the recipient of a significant decline in short interest in the month of June. As of June 15th, there was short interest totaling 11 shares, a decline of 84.1% from the May 31st total of 69 shares. Based on an average daily volume of 1,322 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the business. Comprehensive Wealth Management LLC boosted its holdings in Innovator IBD Breakout Opportunities ETF by 122.0% in the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after purchasing an additional 12,859 shares during the last quarter. Susquehanna International Group LLP raised its stake in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after buying an additional 7,817 shares during the last quarter. Finally, Osaic Holdings Inc. raised its stake in shares of Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after buying an additional 597 shares during the last quarter.

Innovator IBD Breakout Opportunities ETF Price Performance

NYSEARCA:BOUT traded down $0.95 during midday trading on Friday, hitting $47.90. The company’s stock had a trading volume of 4,738 shares, compared to its average volume of 4,305. Innovator IBD Breakout Opportunities ETF has a fifty-two week low of $35.05 and a fifty-two week high of $49.41. The firm’s 50 day moving average is $46.16 and its 200-day moving average is $41.53. The firm has a market cap of $16.77 million, a P/E ratio of 28.69 and a beta of 1.04.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.